Extracorporeal membrane oxygenation combined with intra-aortic balloon counterpulsation for pheochromocytoma: A case report

Table 1 Laboratory test results at admission

Laboratory tests	Time
	April 11	April 12	April 15	April 18	April 21	April 24	April 25
Blood
WBC (109/L)	33.8	24.9	16.1	11.9	31.8	12.7	20.1
Lymph (%)	17	4.4	12.4	17.4	6.6	7.1	3.6
Neut (%)	79.8	93	81.1	72	89.6	88.6	93.5
Hb (g/L)	163	137	106	73	71	73	81
Plt (109/L)	198	102	58	65	120	203	250
C-reactive protein	< 0.2	78.2	51.8	28.5	37.9	55.9	63.3
PCT (ng/mL)	0.03	3.949	1.268	0.585	0.578	-	-
K (mmol/L)	2.75	3.24	3.9	4.62	3.71	4.17	3.95
Na (mmol/L)	135.7	145.5	146.7	144.5	144.3	144.6	135.6
Creatinine (μmol/L)	97	78	65	60	45	43	42
GFR (mL/minute)	63	82	102	109	120	122	123
D-D (mg/L)	> 30	6.06	13.83	> 30	12.97	10.44	12.12
APTT (second)	23.6	60.6	48.2	35.9	38	21.9	24.7
Blood gas analysis
PH	7.326	7.385	7.513	7.399	7.441	7.432	7.449
Lactic acid (mmoL/L)	10.1	3.1	1.3	1.1	1	0.8	0.6
HCO3- (mmoL/L)	17.1	23	37.7	27.5	23.6	24.8	25.1
P/F (mmHg)	192	328	175	429	475	501	474
Myocardial enzyme
CK (U/L)	152	308	1255	2423	1534	716	357
CK-MB (ng/mL)	4.22	22.50	20.94	25.95	26.56	12.09	9.98
CTnI (μg/L)	0.281	4.287	1.119	0.73	0.614	-	-
NT-proBNP (pg/mL)	302	5665	7240	6566	5717	-	-

April 12: Line after extracorporeal membrane oxygenation (ECMO) and intra-aortic balloon counterpulsation (IABP); April 15: The third day of ECMO and IABP use; April 18: After ECMO withdrawal; April 21: Before IABP withdrawal; April 24: After IABP withdrawal; April 25: Vital signs are stable, various indicators have improved, and it is ready to be transferred to the general ward for surgical treatment. WBC: White blood cell; Hb: Hemoglobin; Plt: Platelet; PCT: Procalcitonin; GFR: Glomerular filtration rate; D-D: D-dimer; APTT: Activated partial thromboplastin time; P/F: Oxygenation index; CK: Creatine kinase; CK-MB: Creatine kinase isoenzyme; CTnI: High-sensitivity troponin I; NT-proBNP: N-terminal pro-B-type natriuretic peptide.